FinLnq
THE CHALLENGE
Biotech companies must make capital decisions against long development timelines, uncertain milestones, and finite runway. Small changes in hiring, program timing, operating spend, or financing assumptions can materially affect how far existing capital will carry the business.
When runway visibility is limited or capital planning is disconnected from development priorities, leadership can lose flexibility at exactly the wrong time.
THE SOLUTION
FinLnq helps biotech companies connect financial planning directly to development strategy.
Our professionals support runway analysis, capital planning, forecasting, scenario modeling, financing readiness, and fundraising preparation so leadership can understand the financial implications of key decisions before they are made.
Whether preparing for the next financing, reassessing operating priorities, or planning around a critical development milestone, FinLnq provides the financial perspective and execution needed to make capital decisions with greater confidence.
CORE AREAS OF SUPPORT
Burn Rate & Runway Management
Build clear visibility into current burn, projected cash requirements, and the timing of future capital needs.
Capital Planning & Forecasting
Translate development plans, hiring assumptions, and operating priorities into integrated financial forecasts.
Financial Modeling & Scenario Planning
Model alternative development, hiring, financing, and operating scenarios to understand their impact on runway and capital requirements.
Financing & Fundraising Readiness
Prepare financial materials, projections, assumptions, and supporting analysis for upcoming financing activity.
Venture Financing Preparation
Support management teams with the financial planning and analysis required for venture discussions, diligence, and investor review.
Development Milestone Planning
Connect financial planning to scientific and clinical milestones so leadership can understand what the current capital base can realistically support.
Board & Investor Financial Support
Prepare clear financial reporting, forecasts, runway updates, and scenario analysis for board and investor discussions.
.jpg)
OUR COMMITMENT TO BIOTECH LEADERS
Capital decisions should support the science, not compete with it.
FinLnq helps leadership teams understand the financial tradeoffs behind development decisions and allocate capital around the milestones that matter most.
Our role is to provide clear analysis, experienced judgment, and practical execution so leadership can make decisions with a stronger understanding of runway, timing, and financing risk.
HOW WE ENGAGE
Finance expertise matched to the stage and need.
FinLnq can support companies through fractional or interim CFO leadership, focused capital planning projects, financial modeling, fundraising preparation, or ongoing strategic finance support.
Engagements can expand or narrow as financing activity, development priorities, and organizational needs change.
WHY FINLNQ
Because biotech capital planning is inseparable from drug development.
A biotech forecast is more than a budget. It reflects development timelines, clinical milestones, hiring plans, manufacturing needs, financing assumptions, and strategic choices about where capital is deployed.
FinLnq brings finance professionals who understand that environment and can translate development plans into the financial decisions required to support them.